Celcuity (CELC) Operating Leases (2019 - 2026)

Celcuity's (CELC) quarterly Operating Leases came in at $54000.0 in Q4 2025, little changed YoY from $54000.0 in Q4 2024, and up 315.38% on a QoQ basis from $13000.0 in Q1 2025.

Celcuity (CELC) Operating Leases (2019 - 2026) Analysis & Trends

Celcuity (CELC) has 7 years of Operating Leases data on file, last reported at $54000.0 in Q4 2025.

  • Quarterly Operating Leases changed 0.0% year-over-year to $54000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $54000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $54000.0, changed 0.0% from the prior year.
  • Operating Leases advanced to $54000.0 in Q4 2025, from $13000.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $363961.0 in Q1 2023 to a low of $13000.0 in Q1 2025.
  • A 5-year average of $154218.7 and a median of $138533.0 in 2024 frame the typical range for Operating Leases.
  • Annual changes were most pronounced in 2022 — Operating Leases surged 1251.44% — and 2025, when it plunged 92.86%.
  • Tracing CELC's Operating Leases over 5 years: stood at $61771.0 in 2021, then retreated by 1.24% to $61002.0 in 2022, then surged by 270.35% to $225922.0 in 2023, then tumbled by 76.1% to $54000.0 in 2024, then changed by 0.0% to $54000.0 in 2025.
  • The last three Operating Leases figures came in at $54000.0 (Q4 2025), $13000.0 (Q1 2025), and $54000.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Celcuity 4.50 Bn 4.50 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2026 893,000.00
Dec 31, 2025 54,000.00
Mar 31, 2025 13,000.00
Dec 31, 2024 54,000.00
Sep 30, 2024 95,699.00
Jun 30, 2024 138,533.00
Mar 31, 2024 182,079.00
Dec 31, 2023 225,922.00
Sep 30, 2023 270,925.00
Jun 30, 2023 317,120.00
Mar 31, 2023 363,961.00
Dec 31, 2022 61,002.00
Sep 30, 2022 107,830.00
Jun 30, 2022 156,769.00
Mar 31, 2022 204,595.00
Dec 31, 2021 61,771.00
Sep 30, 2021 299,373.00
Mar 31, 2021 15,139.00
Dec 31, 2020 53,000.00
Sep 30, 2020 107,040.00